ALRN-6924

Aileron Terminates Phase 1b Breast Cancer Chemoprotection Trial Of ALRN-6924
NASDAQ
Tue, 02/21/23 - 04:34 pm
Aileron Therapeutics
clinical trials
breast cancer
ALRN-6924